Update from ENETS 2026

Prof. Louis de Mestier, MD, PhD, is Full Professor of Gastroenterology at Université Paris-Cité, and serves as a Senior Consultant in the Department of Pancreatology and Digestive Oncology in Beaujon Hospital (APHP, Clichy, France). His main area of clinical expertise, research and teaching is digestive neuroendocrine neoplasms. He conducts clinical and translational research on the clinical and biological heterogeneity of neuroendocrine neoplasms and its therapeutic applications at the INSERM U1149 Research Unit in Paris. He has contributed to more than 170 medical publications, including more than 100 indexed papers in the field of neuroendocrine neoplasms. He is a member of the Advisory Boards of ENETS and GTE.

Timon Vandamme is a Senior Consultant in digestive and neuroendocrine oncology at the Antwerp University Hospital. As a clinician-researcher, he is performing research in circulating cell-free DNA (ccfDNA) in digestive and neuroendocrine neoplasms.

Dr Vandamme obtained a joint PhD at the University of Antwerp, Belgium and the Erasmus MC, the Netherlands, on preclinical and translation evaluation of everolimus resistance and pancreatic NET genomics. His PhD project has led to multiple publications in peer-reviewed journals and received numerous awards, both national and international. Currently, he is holder of a Senior Clinical Investigator (FKM) grant of the Fonds Wetenschappelijk Onderzoek (FWO) at the University of Antwerp.

Furthermore, he is the Principal Investigator (PI) of > 10 trials at the University Hospital Antwerp, both industry-sponsored and academic trials. He is promotor of four PhD students and mentor of two additional PhD students. He has authored numerous papers outside his PhD in journals such as Clinical Cancer Research and Lancet Oncology. He has peer-reviewed for different high-impact journals and is a member of the editorial board of Endocrine-Related Cancer.

He is currently acting secretary of the Dutch Belgian Neuroendocrine Tumor Society (DBNETS) and co-opted board member of the Belgian Group of Digestive Oncology (BGDO). In addition, he is active member of the EORTC GI Tract Cancer Group and the ENETS Translational Working Group.

Medical oncologist at the Hospices Civils de Lyon (France), specialising in digestive oncology and neuroendocrine tumours, working in the nuclear medicine department as part of the PRRT programme.

Areas of research are particularly PRRT lung carcinoids, and issues relating to care pathways for rare tumours.